(1) Department of General Pediatrics, Medical Faculty, University Dusseldorf, Moorenstrasse 5, 40225 D?sseldorf, Germany;(2) Medical Faculty, Institute for Diagnostic Radiology, University Dusseldorf, 40225 Dusseldorf, Germany
Abstract:
Objective
The implementation of NTBC into treatment of hypertyrosinemia type I (HT I) greatly improved survival by prevention of acute liver failure and hepatocellular carcinoma. However, there are first reports of cognitive impairment in patients with elevated plasma tyrosine concentrations.